Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2016-12-12 | Amended | $300,000 | $0 | Other | 06b | SEC link |
| 2016-05-13 | New | $300,000 | $300,000 | Other | 06b | SEC link |
| 2014-08-04 | Amended | $7,541,206 | $250,000 | Equity Only | 06b | SEC link |
| 2014-04-17 | Amended | $7,291,206 | $250,000 | Equity and Debt | 06b | SEC link |
| 2013-08-13 | Amended | $7,041,206 | $0 | Equity Only | 06 | SEC link |
| 2013-02-11 | Amended | $7,041,206 | $250,000 | Equity and Debt | 06 | SEC link |
| 2011-07-18 | Amended | $6,791,206 | $750,001 | Equity and Debt | 06 | SEC link |
| 2010-04-06 | Amended | $6,041,205 | $1,000,000 | Equity Only | 06 | SEC link |
| 2009-07-28 | New | $5,041,205 | $5,041,205 | Equity Only | 06 | SEC link |
| 2008-08-28 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Brian K. Adamsky | Director |
| Joseph Berardino | Director |
| Donald Caldwell | Director |
| Michael Greenebaum | Director |
| Stewart J. Greenebaum | Director |
| William Haseltine | Director |
| Reinhard A. Kurth | Director |
| Terry Lierman | Director |
| Thomas A. Lynch | Director |
| Jeffrey N. Meshulam | Director, Executive |
| Shawn Patrick O'brien | Director, Executive |
| Thomas G. Paese | Executive |
| Tom Pease | Executive |
| Thomas G. Pease | Director, Executive |
| Alexander G. Rich | Director, Executive |
| M.G. Sarngadharan | Director |
| M.G. Sarngaharan | Executive |
| Jeffrey Stello | Executive |
| Frederick C. Tecce | Director |